Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry
Provided By PR Newswire
Last update: Sep 26, 2024
Mirai's machine intelligence-based, open platform unlocks delivery to any tissue and cell type through rapid, iterative learning of in vivo tested chemistries
Read more at prnewswire.com5.23
-0.15 (-2.79%)
35.53
+1.8 (+5.34%)
0.1599
+0.01 (+3.83%)
3.01
-0.05 (-1.63%)
Find more stocks in the Stock Screener
